5 models fit Interparfums Inc. Common Stock and they disagree: 2 of 5 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Silver70
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionInterparfums Inc. Common Stock (IPAR)
Fair value (5 models)
$95.57
ACCE price target
$105
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 15:04 CEST; previously $156 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 11 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 15:04 CEST.
Price used: $115 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
20.6% above
-17.1% to fair value
ACCE score
62
out of 100
Analysts
33% buy
6 covering
P/E
22.0x
forward 22.1x
1-year return
+17.6%
Dividend yield
2.76%
Interparfums Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Interparfums licenses and distributes prestige fragrances under brands such as Lacoste, Coach, Hollister and Jimmy Choo, with Montblanc and Abercrombie & Fitch also in its portfolio, and sells them through department stores and specialty retail. Its edge is the licensing model: partners such as Lacoste supply the brand equity and Interparfums carries the development, manufacturing and distribution cost, which underpins a 58.4% gross margin. Revenue growth has slowed to 2.1%, so the case rests on whether mix and margin hold up rather than on top-line acceleration. At 22.0 times trailing earnings and 23.6 times forward, the stock is priced for steady execution, not a rebound. With a 19.1% return on equity and a 12.3% operating margin, the business is profitable, but the score of 59/100 and the lack of index membership suggest it is a niche name worth a closer look only if you believe the licensing franchises can re-accelerate.
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
moderate
Earnings declining despite revenue growth
Revenue grew 2.1% year on year while earnings fell 4.0%, and revenue fell 10.6% quarter on quarter. Net margin of 11.2% is thin for a company carrying this brand-licensing exposure.
moderate
Insider selling with no buying
Insiders disclosed $5.78M of sales across the last 10 filings and no purchases. Insiders own 43.6% of shares, so this selling is worth tracking.
moderate
Score slipping over 90 days
The ACCE score fell from 62 to 60 over 90 days, with growth at 19 the weakest component. Small move, but the direction has been consistently down.
AI research notes
AI-assisted·How I use AIWritten Oct 19, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Free cash flow over the last twelve months reached $190M, a solid cash base for a business of this kind.
Return on equity of 19.1% and a debt to equity ratio of 0.25 show profitable use of shareholder money with modest borrowing.
Why it could disappoint
Revenue grew only 2.1% over the past year, far below the 22.5% annual pace of the last five years.
The latest quarter missed expectations, with earnings per share of 0.95 against 1.04 expected, an 8.7% shortfall.
The stock trades at a forward P/E of 23.6x against a sector median of 18.3x, a premium that growth has not justified.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where IPAR's valuation models land
Price
$115.22
Model fair value
$95.57
Model range
$56.71 to $149
Fair value $95.57
Price $115
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores